Related Experiment Videos

Glutathione protects a human insulinoma cell line from tumor necrosis factor-alpha-mediated cytotoxicity

M G Cavallo1, L Monetini, L Valente

  • 1Istituto II Clinica Medica, University of Rome La Sapienza, Italy.

International Journal of Clinical & Laboratory Research
|January 1, 1997
PubMed

Insights

Glutathione protects beta-cells from damage caused by tumor necrosis factor-alpha. This finding suggests glutathione may be beneficial in preventing beta-cell loss in insulin-dependent diabetes.

Area of Science:

  • Immunology
  • Endocrinology
  • Cell Biology

Background:

  • Cytokine-mediated cytotoxicity is implicated in beta-cell destruction in insulin-dependent diabetes.
  • Tumor necrosis factor-alpha (TNF-α) is a key cytokine contributing to beta-cell damage.
  • Glutathione, a free oxygen radical scavenger, is investigated for its potential protective role.

Purpose of the Study:

  • To investigate the effect of glutathione in preventing TNF-α-mediated cytotoxic damage to a human beta-cell line (CM insulinoma) in vitro.
  • To determine if glutathione can mitigate the harmful effects of TNF-α on beta-cells.

Main Methods:

  • Human beta-cell line (CM insulinoma) cells were exposed to TNF-α, TNF-α plus glutathione, or glutathione alone at varying concentrations.
  • Cytotoxicity was quantified using a colorimetric assay.

Main Results:

  • Glutathione significantly reduced TNF-α-mediated cytotoxicity in a dose-dependent manner (P < 0.001).
  • Glutathione alone did not induce significant cytotoxicity.

Conclusions:

  • Glutathione demonstrates a protective effect against TNF-α-induced beta-cell cytotoxicity in vitro.
  • These findings support the potential therapeutic use of glutathione in mitigating beta-cell damage in insulin-dependent diabetes.

Related Concept Videos